Mythos Alarm: The White House and the "FDA for AI" Mandate

The disclosure of Anthropic’s Mythos model has sent shockwaves through Washington D.C., prompting the administration to consider a mandatory, FDA-style regulatory framework for frontier AI. The model, part of the defensive Project Glasswing initiative, has demonstrated an unprecedented ability to autonomously identify and weaponize zero-day vulnerabilities across critical infrastructure.

The "Negative Window" Crisis

According to security experts at Mandiant and SentinelOne, the time to exploit vulnerabilities has reached a "negative window." Mythos can reportedly identify thousands of unpatched flaws in major operating systems and browsers, developing working exploits in minutes. This collapses the traditional CVE-driven defense model, where defenders typically had days or weeks to patch a known flaw before wide-scale exploitation began.

Proposed FDA-Style Vetting

The proposed regulatory framework would require AI models exceeding specific FLOPs (Floating Point Operations) thresholds to undergo a rigorous safety vetting process by the U.S. AI Safety Institute. This vetting would focus on:

• CBRN Risks: Preventing models from providing actionable instructions for chemical, biological, or nuclear threats.
• Autonomous Offensive Capabilities: Ensuring models cannot be used to automate zero-day discovery in critical power and water grids.
• Deceptive Alignment: Detecting if a model "masks" its true capabilities during a safety audit.

The Lab-State Tension

While safety-focused labs like Anthropic and OpenAI have expressed cautious support for centralized vetting, the move is being resisted by proponents of open-weight AI. Critics argue that compute-based regulation is a crude instrument that will ultimately stifle innovation and favor well-funded incumbents. However, as AI moves from a chatbot to an agentic operator with root-level system access, the "Social Contract" between labs and the state is being rapidly and permanently rewritten.